Texas 2025 - 89th Regular

Texas Senate Bill SB2257 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1	89R5865 MPF-D
2	2	By: Cook S.B. No. 2257
3	3
4	4
5	5
6	6
7	7	A BILL TO BE ENTITLED
8	8	AN ACT
9	9	relating to the definition and provision of an abortion-inducing
10	10	drug.
11	11	BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
12	12	SECTION 1. Section 171.061(2), Health and Safety Code, is
13	13	amended to read as follows:
14	14	(2) "Abortion-inducing drug" means a drug, a medicine,
15	15	or any other substance, including a regimen of two or more drugs,
16	16	medicines, or substances, prescribed, dispensed, or administered
17	17	with the intent of terminating a clinically diagnosable pregnancy
18	18	of a woman and with knowledge that the termination will, with
19	19	reasonable likelihood, cause the death of the woman's unborn
20	20	child. The term includes off-label use of drugs, medicines, or
21	21	other substances known to have abortion-inducing properties that
22	22	are prescribed, dispensed, or administered with the intent of
23	23	causing an abortion, including the Mifeprex regimen, and
24	24	misoprostol (Cytotec)[, and methotrexate]. The term does not
25	25	include a drug, medicine, or other substance that may be known to
26	26	cause an abortion but is prescribed, dispensed, or administered for
27	27	other medical reasons.
28	28	SECTION 2. Section 171.063(c), Health and Safety Code, is
29	29	amended to read as follows:
30	30	(c) Before the physician provides an abortion-inducing
31	31	drug, the physician must:
32	32	(1) examine the pregnant woman in person;
33	33	(2) independently verify that a pregnancy exists;
34	34	(3) [document, in the woman's medical record, the
35	35	gestational age and intrauterine location of the pregnancy to
36	36	determine whether an ectopic pregnancy exists;
37	37	[(4)] determine the pregnant woman's blood type, and
38	38	for a woman who is Rh negative, offer to administer Rh
39	39	immunoglobulin (RhoGAM) at the time the abortion-inducing drug is
40	40	administered or used or the abortion is performed or induced to
41	41	prevent Rh incompatibility, complications, or miscarriage in
42	42	future pregnancies;
43	43	(4) [(5)] document whether the pregnant woman
44	44	received treatment for Rh negativity, as diagnosed by the most
45	45	accurate standard of medical care; and
46	46	(5) [(6)] ensure the physician does not provide an
47	47	abortion-inducing drug for a pregnant woman whose pregnancy is more
48	48	than 49 days of gestational age.
49	49	SECTION 3. (a) The changes in law made by this Act apply
50	50	only to an offense committed on or after the effective date of this
51	51	Act. An offense committed before the effective date of this Act is
52	52	governed by the law in effect on the date the offense was committed,
53	53	and the former law is continued in effect for that purpose. For
54	54	purposes of this section, an offense was committed before the
55	55	effective date of this Act if any element of the offense occurred
56	56	before that date.
57	57	(b) The changes in law made by this Act apply only to the
58	58	imposition of an administrative penalty for a violation that occurs
59	59	on or after the effective date of this Act. The imposition of an
60	60	administrative penalty for a violation that occurs before the
61	61	effective date of this Act is governed by the law in effect on the
62	62	date the violation occurred, and the former law is continued in
63	63	effect for that purpose.
64	64	SECTION 4. This Act takes effect September 1, 2025.